For instance, mir-146a negatively modulates T-cell adhesion and blocks M1 macrophage activation by inhibiting the NFκB pathway, which could be used as a therapeutic strategy in some neurodegenerative diseases (e.g., Alzheimer’s disease) [28,29,30]. This evidence concerns the gene NFKB1 and early-onset autosomal dominant Alzheimer disease.